An Oklahoma judge has found that Johnson & Johnson and its subsidiaries helped fuel the state's opioid crisis and ordered the US consumer products giant to pay $572 million to clean up the problem
"The opioid crisis has ravaged the state of Oklahoma," Cleveland County District Judge Thad Balkman said before announcing the verdict."It must be abated immediately."
An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries had helped fuel the state's opioid crisis and ordered the US consumer products giant to pay $572 million to clean up the problem. "The opioid crisis has ravaged the state of Oklahoma," Balkman said before announcing the verdict. "It must be abated immediately."The US health care giant said it would appeal, and seek to put payment of the award on hold during the appeal process.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Judge fines Johnson & Johnson $572 million for role in Oklahoma opioid caseJohnson & Johnson ordered to pay $572 million in Oklahoma opioid case
Read more »
Johnson & Johnson must pay over $572 million for its role in Oklahoma opioid crisis, judge rulesOklahoma's attorney general claimed that the company marketed opioids to doctors while downplaying the risks of the addictive painkillers since the 1990s.
Read more »
Johnson & Johnson Ordered to Pay $572 Million in Oklahoma Opioid CaseJohnson & Johnson must pay $572 million for contributing to an opioid-addiction crisis in Oklahoma, a judge there ruled in a closely watched trial. The company said it would appeal the judgment.
Read more »
Johnson & Johnson Ordered To Pay $572 Million In Landmark Opioid CaseSuit sought to hold company responsible for spread of addictive painkillers.
Read more »
Oklahoma judge finds J&J liable in opioid epidemic, orders $572 million damagesAn Oklahoma judge orders Johnson & Johnson to pay $572 million after ruling the drugmaker liable for fueling an opioid epidemic in the state by deceptively marketing painkillers
Read more »